IBM, MedyMatch to Develop Brain Imaging Technology

MedyMatch, an Israeli-based tech company, stated on Thursday that it will integrate with  IBM (IBM) Watson Health to create pictures for hospital imaging experts to help doctors identify intracranial bleeding from head trauma and stroke.

At first, IBM Watson Health will issue a MedyMatch brain bleed detection application worldwide. Next, IBM Watson Health and MedyMatch will generate interoperability between MedyMatch's application and IBM Watson Health Imaging's offerings.

The initial deal is a five-year license agreement that will result in several millions of dollars in annual recurring licensing fees to MedyMatch.

More from Investing

Jim Cramer Likes UAL - Watch Oil or Wait for Weakness Before Buying

Jim Cramer Likes UAL - Watch Oil or Wait for Weakness Before Buying

Discounted Cash Flow Valuation: Definition, Investing and Stocks

Discounted Cash Flow Valuation: Definition, Investing and Stocks

Starbucks Shares Gain as Investor Day Highlights China Growth Ambitions

Starbucks Shares Gain as Investor Day Highlights China Growth Ambitions

Chart of the Day: There are Better Bargains Out There Besides GE

Chart of the Day: There are Better Bargains Out There Besides GE

Profit From the Bearish Action in the Russell 2000

Profit From the Bearish Action in the Russell 2000